John O’Brien, CEO of S3 Connected Health, has been announced as the new chair of The Irish Medtech Association (IMA), the Ibec group that represents the medtech sector.
With over 30 years of experience in medtech and technology, John is at the forefront of the industry and brings a wealth of knowledge, insight, and expertise to this role. This makes him perfectly positioned to represent Ireland’s vibrant medtech hub and help elevate Ireland and Irish-based companies internationally.
The IMA has more than 250 members, located throughout Ireland. The group’s broad focus is to promote and support an environment that encourages the sustainable development and profitable growth of FDI multinational and SME member companies. The association believes the Irish industry could take a greater share of the global medtech market, which is forecast to grow to €530 billion by 2024.
As a global medtech hub, Ireland has a unique proposition thanks to strong manufacturing capabilities and an ecosystem of 450 medtech companies. Digital health is also emerging as a dynamic sector promising strong growth opportunities from the 100 plus companies based here.
John O’Brien, CEO, S3 Connected Health: “Ireland is home to some of the most innovative medtech companies in the world, offering huge potential in the development of pioneering medtech solutions. As IMA Chair, I’m committed to fulfilling this potential by building on our current success and enabling Irish companies to embrace new technologies such as artificial intelligence, data analytics, and 3D printing so they’re fully equipped to meet the manufacturing and R&D needs of the future”
“To continue advancing our capabilities, we’re also working on several initiatives to nurture collaboration between medtech, pharma, and technology companies in the specific area of digital health. We believe Ireland has the potential to quickly become a global hub for digital health. We are enabling the ecosystem in many ways including supporting education and training, ecosystem mapping, and raising awareness of the digital health opportunity.
“The need for collaboration across the industry has never been more evident than it is now, as member companies look to provide solutions to help tackle the global pandemic. IMA members will continue to play a vital role manufacturing and supplying lifesaving technology and medical devices that support frontline health workers in the fight against COVID-19.”
